These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 649516)

  • 1. A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. II. Isolation and characterization of a shikimate excreting auxotrophic mutant of Nocardia mediterranei with normal rifamycin-production.
    Ghisalba O; Nüesch J
    J Antibiot (Tokyo); 1978 Mar; 31(3):215-25. PubMed ID: 649516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. I. Isolation and characterization of a pentose-excreting auxotrophic mutant of Nocardia mediterranei with drastically reduced rifamycin production.
    Ghisalba O; Nüesch J
    J Antibiot (Tokyo); 1978 Mar; 31(3):202-14. PubMed ID: 649515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. III. Isolation and identification of an early aromatic ansamycin-precursor containing the seven-carbon amino starter-unit and three initial acetate/propionate-units of the ansa chain.
    Ghisalba O; Fuhrer H; Richter WJ; Moss S
    J Antibiot (Tokyo); 1981 Jan; 34(1):58-63. PubMed ID: 7251510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. IV. Identification of 3-amino-5-hydroxybenzoic acid as a direct precursor of the seven-carbon amino starter-unit.
    Ghisalba O; Nüesch J
    J Antibiot (Tokyo); 1981 Jan; 34(1):64-71. PubMed ID: 7251511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New rifamycins produced by a recombinant strain of Nocardia mediterranei.
    Schupp T; Traxler P; Auden JA
    J Antibiot (Tokyo); 1981 Aug; 34(8):965-70. PubMed ID: 7319929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ansamycin biogenesis: studies on a novel rifamycin isolated from a mutant strain of Nocardia mediterranei.
    White RJ; Martinelli E; Lancini G
    Proc Natl Acad Sci U S A; 1974 Aug; 71(8):3260-4. PubMed ID: 4528428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. V. Studies on the biogenetic origin of 3-substituents.
    Traxler P; Ghisalba O
    J Antibiot (Tokyo); 1982 Oct; 35(10):1361-6. PubMed ID: 7174520
    [No Abstract]   [Full Text] [Related]  

  • 8. Study to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei.
    Gygax D; Ghisalba O; Treichler H; Nüesch J
    J Antibiot (Tokyo); 1990 Mar; 43(3):324-6. PubMed ID: 2324014
    [No Abstract]   [Full Text] [Related]  

  • 9. Rifamycin biosynthesis: further studies on origin of the ansa chain and chromophore.
    Karlsson A; Sartori G; White RJ
    Eur J Biochem; 1974 Sep; 47(2):251-6. PubMed ID: 4415635
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of low molecular weight regulators on the biosynthesis of rifamycin B by Amycolatopsis mediterranei strains].
    Bushueva OA; Efremenkova OV; Gorin SE; Bartoshevich IuE
    Antibiot Khimioter; 1991 Mar; 36(3):11-5. PubMed ID: 1877868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of mycelium morphological characteristics and rifamycin B production using Nocardia mediterranei.
    Lee KJ; Rho YT
    J Biotechnol; 1994 Aug; 36(3):239-45. PubMed ID: 7765266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early intermediates in the biosynthesis of ansamycins. I. Isolation and identification of protorifamycin I.
    Ghisalba O; Traxler P; Nüesch J
    J Antibiot (Tokyo); 1978 Nov; 31(11):1124-31. PubMed ID: 721708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of industry-applied rifamycin B-producing strain, Amycolatopsis mediterranei, by rational screening.
    Jin ZH; Lin JP; Xu ZN; Cen PL
    J Gen Appl Microbiol; 2002 Dec; 48(6):329-34. PubMed ID: 12682871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Amino-5-hydroxybenzoic acid synthase, the terminal enzyme in the formation of the precursor of mC7N units in rifamycin and related antibiotics.
    Kim CG; Yu TW; Fryhle CB; Handa S; Floss HG
    J Biol Chem; 1998 Mar; 273(11):6030-40. PubMed ID: 9497318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regulatory effects of terminal products and intermediates of aromatic pathways on rifamycin biosynthesis in Nocardia mediterranei].
    Gu WL; Xia TH; Jiao RS
    Wei Sheng Wu Xue Bao; 1988 Mar; 28(1):56-61. PubMed ID: 2898835
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of B-factor and its analogues on rifamycin biosynthesis in Nocardia sp.
    Kawaguchi T; Azuma M; Horinouchi S; Beppu T
    J Antibiot (Tokyo); 1988 Mar; 41(3):360-5. PubMed ID: 3366694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiazorifamycins. III. Biosynthesis of rifamycins P, Q and verde, novel metabolites from a mutant of Nocardia mediterranea.
    Cricchio R; Antonini P; Sartori G
    J Antibiot (Tokyo); 1980 Aug; 33(8):842-6. PubMed ID: 7429988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis and reconstituted expression of the biosynthetic genes involved in the formation of 3-amino-5-hydroxybenzoic acid, the starter unit of rifamycin biosynthesis in amycolatopsis Mediterranei S699.
    Yu TW; Muller R; Muller M; Zhang X; Draeger G; Kim CG; Leistner E; Floss HG
    J Biol Chem; 2001 Apr; 276(16):12546-55. PubMed ID: 11278540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic recombination in Nocardia mediterranei.
    Schupp T; Hutter R; Hopwood DA
    J Bacteriol; 1975 Jan; 121(1):128-36. PubMed ID: 1116983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 16,17-dihdrorifamycin S and 16,17-dihydro-17-hydroxyrifamycin S. Two novel rifamycins from a recombinant strain C 5/42 of Nocardia mediterranei.
    Traxler P; Schupp T; Wehrli W
    J Antibiot (Tokyo); 1982 May; 35(5):594-601. PubMed ID: 7107523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.